As of July 13, 2026, Cartesian Therapeutics, Inc. (RNAC) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. Cartesian Therapeutics, Inc. has a market capitalization of $221.54M, 29.38M shares outstanding, 83 institutional holders tracked. Key dilution vectors include 196.8K outstanding warrants, approximately 22 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RNAC.
💹 Market Data
Market Cap$221.54M
Shares Outstanding29.38M
Float9.57M
Cash$130.12M
Debt$11.86M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 45.4% shares (2026Q1 vs prior)
83 institutional holders · 7.68M shares
#1
Squarepoint Ops LLC
2.24M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
815.2K shares
#3
FMR LLC
799.7K shares
📉 Short Interest
Short Interest1.89M
Days to Cover4.9
% of Float19.7%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2016
4
INSIDER TRANSACTION
Apr 06, 2026
4
INSIDER TRANSACTION
Apr 06, 2026
4
INSIDER TRANSACTION
Mar 13, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for RNAC Shareholders
Cartesian Therapeutics, Inc. (RNAC) has a DilutionScore of 38/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.
DilutionWatch tracks 196,850 outstanding warrants for RNAC. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.
DilutionWatch tracks over 25 SEC filing types for RNAC in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RNAC alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track RNAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RNAC — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for RNAC
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.